BIO-key reports Q3 software license growth, gross margin expansion
In Q3 2026, BIO-key reported a 39% increase in software license fees and a net loss narrower than a year earlier. The company announced solid business momentum, driven by Middle East government wins and improved margins.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed